Stepwise deletion of the HIV type 1 glycoprotein 41 N terminus leads to an increasing export of microvesicles containing uncleaved Env glycoprotein

AIDS Research and Human Retroviruses

Volumn 17, Issue 14, 2001, Pages 1345-1356

  Adams, Ortwin ^a   Scheid, Andreas ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 41; GLYCOSIDASE; MEMBRANE PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS VECTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MUTANT; CELL SURFACE; CONTROLLED STUDY; CULTURE MEDIUM; GENETIC TRANSFECTION; HELA CELL; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; SIALYLATION; STEM CELL;

AMINO ACID SEQUENCE; AMINO ACIDS; BINDING SITES; CENTRIFUGATION, DENSITY GRADIENT; CYTOPLASMIC VESICLES; GENE PRODUCTS, ENV; GLYCOPROTEINS; GLYCOSIDE HYDROLASES; HELA CELLS; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; MEMBRANE FUSION; MOLECULAR SEQUENCE DATA; MUTATION; NEURAMINIDASE; PROTEIN PRECURSORS; REGULATORY SEQUENCES, NUCLEIC ACID; SEQUENCE DELETION;

EID: 0034760994     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/08892220152596605     Document Type: Article

References (51)

1. Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160
2. Comparative functional role of PC7 and furin in the processing of the HIV envelope glycoprotein gp160
3. The convertases furin and PC1 can both cleave the human immunodeficiency virus (HIV)-1 envelope glycoprotein gp160 into gp120 (HIV-1 SU) and gp41 (HIV-1 TM)
4. Mutational analysis of the human immunodeficiency virus type 1 env gene product proteolytic cleavage site
5. Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage
6. Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: Requirement of precursor cleavage for glycoprotein incorporation
7. Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus
8. A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity
9. Mutational analysis of the fusion peptide of the human immunodeficiency virus type 1: Identification of critical glycine residues
10. Effects of second-site mutations on dominant interference by a human immunodeficiency virus type 1 envelope glycoprotein mutant
11. Attenuation of human immunodeficiency virus type 1 cytopathic effect by a mutation affecting the transmembrane envelope glycoprotein
12. Membrane fusion induced by the HIV type 1 fusion peptide: Modulation by factors affecting glycoprotein 41 activity and potential anti-HIV compounds
13. Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41
14. Natural variation in the amino acid sequence around the HIV type 1 glycoprotein 160 cleavage site and its effect on cleavability, subunit association, and membrane fusion
15. 2-terminal domain of the HIV2 gp41
16. Requirement of N-terminal amino acid residues of gp41 for human immunodeficiency virus type 1-mediated cell fusion
17. Identification and characterization of fusion and processing domains of the human immunodeficiency virus type 2 envelope glycoprotein
18. Mutational analysis of the cleavage sequence of the human immunodeficiency virus type 1 envelope glycoprotein precursor gp160
19. Intracellular processing of the gp160 HIV-1 envelope precursor. Endoproteolytic cleavage occurs in a cis or medial compartment of the Golgi complex
20. Mutations within the human immunodeficiency virus type 1 gp160 envelope glycoprotein alter its intracellular transport and processing
21. Carbohydrates of human immunodeficiency virus. Structures of oligosaccharides linked to the envelope glycoprotein 120
22. Glycosylation of the envelope glycoprotein gp130 of simian immunodeficiency virus from sooty mangabey (Cercocebus atys)
23. The glycosylation of human immunodeficiency virus type 1 transmembrane glycoprotein (GP41) is important for the efficient intracellular transport of the envelope precursor gp160
24. Assembly of asparagine-linked oligosaccharides
25. Subcellular organization of glycosylation in mammalian cells
26. Alternate pathways of secretion of simian immunodeficiency virus envelope glycoproteins
27. Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations
28. Cell membrane vesicles are a major contaminant of gradient-enriched human immunodeficiency virus type-1 preparations
29. Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions
30. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain
31. The HIV "A" (sor) gene product is essential for virus infectivity
32. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone
33. A syncytia assay for human immunodeficiency virus type I (HIV-1) envelope protein and its use in studying HIV-I mutations
34. The role of envelope glycoprotein processing in murine leukemia virus infection
35. HIV entry and its inhibition
36. Core structure of gp41 from the HIV envelope glycoprotein
37. Atomic structure of the ectodomain from HIV-1 gp41
38. The ectodomain of HIV-1 env subunit gp41 forms a soluble, alpha-helical, rod-like oligomer in the absence of gp120 and the N-terminal fusion peptide
39. The HIV-1 envelope glycoproteins: Fusogens, antigens, and immunogens
40. Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins
41. Retroviral envelope glycoproteins contain a "leucine zipper"-like repeat
42. A trimeric subdomain of the simian immunodeficiency virus envelope glycoprotein
43. A trimeric structural domain of the HIV-1 transmembrane glycoprotein
44. B lymphocytes secrete antigen-presenting vesicles
45. Transport and intracellular distribution of MHC class II molecules and associated invariant chain in normal and antigen-processing mutant cell lines
46. Multivesicular bodies in HEp-2 cells are maturing endosomes
47. Delivery to lysosomes in the human carcinoma cell line HEp-2 involves an actin filament-facilitated fusion between mature endosomes and preexisting lysosomes
48. Human immunodeficiency virus type 1 envelope protein endocytosis mediated by a highly conserved intrinsic internalization signal in the cytoplasmic domain of gp41 is suppressed in the presence of the Pr55gag precursor protein
49. Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers
50. Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1